Detailed definition
The Women's Health Initiative Memory Study (WHIMS) enrolled women aged 65 and older from the WHI hormone arms and assessed cognitive outcomes. WHIMS found a roughly doubled risk of probable dementia in women on CEE+MPA compared to placebo (45 vs. 22 cases per 10,000 woman-years), with a smaller and less consistent signal in the CEE-alone arm. These findings drove the cautionary stance against initiating HRT for cognitive protection in older women. Crucially, WHIMS enrolled women who started HRT for the first time at age 65+ — well outside the timing window. Subsequent observational data and the KEEPS-Cog substudy in younger women starting HRT in the timing window have shown neutral or favorable cognitive effects. The 2022 BMJ analysis on HRT and dementia found generally favorable effects when HRT was started before age 60.
Why it matters in menopause
The WHIMS finding — increased dementia risk with HRT initiation after 65 — is real but specifically applies to older women starting HRT for the first time. It does not generalize to younger women in the timing window, where the cognitive signal looks favorable. This distinction is essential for honest HRT counseling.
Related terms
Sources
External references: Wikipedia.